Medios AG
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MEDOF research report →
Price Chart
About the company
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies.
- CEO
- Thomas Meier
- IPO
- 2021
- Employees
- 993
- HQ
- Berlin, DE
Get TickerSpark's AI analysis on MEDOF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.28B
- P/E
- 24.73
- Fwd P/E
- 36.27
- PEG
- -0.61
- P/S
- 0.13
- P/B
- 0.51
- EV/EBITDA
- 4.89
- Div Yield
- 0.00%
- Gross Margin
- 5.36%
- Op Margin
- 1.92%
- Net Margin
- 0.52%
- ROE
- 2.16%
- ROIC
- 2.41%
Latest fiscal year · YoY change
- Revenue
- $2.08B+10.4%
- Gross Profit
- $199.17M+31.5%
- Op Income
- $42.41M
- Net Income
- $15.37M+22.4%
- EPS
- $0.61+19.6%
- OCF Growth
- -29.0%
- FCF Growth
- -34.7%
- 52W High
- $50.00
- 52W Low
- $13.64
- 50D MA
- $50.00
- 200D MA
- $50.00
- Beta
- 1.29
- RSI (14)
- 0
- Avg Volume
- 67
No earnings-call transcripts are available for MEDOF yet.
- Free Float
- 32.7%
- Shares Outstanding
- 25.51M
- Float Shares
- 8.33M
Our MEDOF coverage
Recent articles, reports, and earnings notes.
No research on MEDOF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MEDOF report →Medios AG (MEDOF) Q2 2026 Earnings Call Prepared Remarks Transcript
seekingalpha.com · Aug 17
Medios AG (MEDOF) Q3 2025 Earnings Call Prepared Remarks Transcript
seekingalpha.com · Nov 11
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.